Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

5.

Spotlight on abciximab in patients with ischemic heart disease undergoing percutaneous coronary revascularization.

Ibbotson T, McGavin JK, Goa KL.

Am J Cardiovasc Drugs. 2003;3(5):381-6. Review.

PMID:
14728074
6.

Clinical pharmacology of eptifibatide.

Phillips DR, Scarborough RM.

Am J Cardiol. 1997 Aug 18;80(4A):11B-20B. Review.

PMID:
9291241
7.
8.

A risk-benefit assessment of abciximab in angioplasty.

Kleiman NS.

Drug Saf. 1999 Jan;20(1):43-57. Review.

PMID:
9935276
10.

An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.

Adgey AA.

Eur Heart J. 1998 Apr;19 Suppl D:D10-21. Review.

PMID:
9597518
12.

Clinical and economic studies of eptifibatide in coronary stenting.

Pasala T, Sattayaprasert P, Bhat PK, Athappan G, Gandhi S.

Ther Clin Risk Manag. 2014 Aug 2;10:603-14. doi: 10.2147/TCRM.S35664. eCollection 2014. Review. Erratum in: Ther Clin Risk Manag. 2014;10:913.

Supplemental Content

Support Center